PRE 14A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: March 25, 2009
Period of Report: May 28, 2009
Accession Number: 0000950135-09-002042

View Document ↗ View on SEC.gov ↗